| Vol. 6.43 – 13 December, 2021 |
| |
|
|
| Alveolar and endothelial injury may be differentially associated with COVID-19 disease severity over time. Scientists described alveolar and endothelial injury dynamics and associations with COVID-19 severity, cardiorenovascular injury, and outcomes. [American Journal of Respiratory and Critical Care Medicine] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| The authors combined analyses of immune cells and cytokine/chemokine networks with endothelial activation and injury. [Signal Transduction and Targeted Therapy] |
|
|
|
| Scientists performd a comprehensive analysis of the plasma proteome of more than 1400 proteins in children with SARS-CoV-2. They showed that protein signatures demonstrated overlap between multi-system inflammatory syndrome in children, and the inflammatory syndromes macrophage activation syndrome and thrombotic microangiopathy. [Nature Communications] |
|
|
|
| Using human cultured endothelial cells, researchers found that endogenous protease-activated receptor-1 (PAR1) and sphingosine-1-phosphate receptor-1 (S1PR1) coexisted in caveolin-1–rich microdomains and that S1PR1 co-association with Cav1 was increased by activated protein C (aPC) activation of PAR1. [Proceedings of the National Academy of Sciences of the United States of America] |
|
|
|
| Scientists studied the role of YAP/TAZ signaling in endothelial cells (ECs) in tumor angiogenesis and found that the expression of YAP/TAZ and downstream target genes in ECs correlated with tumor vascularization in human colorectal carcinomas and skin melanoma. [Science Signaling] |
|
|
|
| The authors showed that miR-29cb2 was a bone-specific miRNA and played critical roles on angiogenesis-osteogenesis coupling during bone remodeling. [iScience] |
|
|
|
| A co-culture of endothelial cells with CRTC1-deficient neurons aggravated the cell vulnerability to hypoxia, supporting the idea that miRNA-132/212 cluster was regulated by CRTC1 and acted as a crucial role in the mitigation of ischemic damage. [Cell Death Discovery] |
|
|
|
| Investigators evaluated the impact of macular fluid features on visual and anatomical outcomes in type 3 macular neovascularization (MNV) patients treated with anti-VEGF. They found that the macular fluid morphology in type 3 MNV showed no significant correlation with visual and anatomical outcomes. [Scientific Reports] |
|
|
|
| Scientists developed a model based on two previously published and experimentally validated mathematical models of calcium and angiogenesis and used resulting models to simulate various multi-cell scenarios. [Scientific Reports] |
|
|
|
| Investigators found that sodium dithionite induced endothelial cell tube formation without matrigel under hypoxia conditions. The angiogenesis related proteins and mRNA at different time points after tube formation were measured both in primary HUVECs and murine microvascular endothelial cell lines. [Microvascular Research] |
| |
|
|
|
| Vascular endothelial growth factor A (VEGF-A) mediates angiogenesis and is upregulated in the plaques and plasma of patients with psoriasis. Targeting VEGF-A in in vivo models of psoriasis-like inflammation results in disease clearance. [British Journal of Dermatology] |
|
|
|
|
| SynDevRx, Inc. announced a research collaboration with Australia’s Queensland University of Technology. The collaboration with Professor Colleen Nelson, PhD, and her team will study the role of methionine aminopeptidase 2 inhibition in tumor growth in castration resistant and other treatment resistant forms of prostate cancer. [SynDevRx, Inc.] |
|
|
|
|
| February 10 – 12, 2022 Lorne, Victoria, Australia |
|
|
|
|
|
| Karolinska Institute – Solna, Sweden |
|
|
|
| University of Mississippi Medical Center – Jackson, Mississippi, United States |
|
|
|
| Stanford University – Palo Alto, California, United States |
|
|
|
| Accession Therapeutics – Oxford, England, United Kingdom |
|
|
|
| University of California Los Angeles – Los Angeles, California, United States |
|
|
|
|